J Appl Phys 1998, 84:6023–6026.CrossRef 19. Jessensky O, Müller F, Gösele U: Self-organized formation of hexagonal pore arrays in anodic alumina. Appl Phys Lett 1998, 72:1173–1175.CrossRef 20. Geyer N, Fuhrmann B, Huang ZP, Boor J, Leipner HS, Werner
P: Model for the mass transport during metal-assisted chemical etching with contiguous metal films as catalysts. J Phys Chem C 2012, 116:13446–13451.CrossRef 21. Rossi RC, Tan MX, Lewis NS: Size-dependent electrical behavior of spatially inhomogeneous barrier height regions on silicon. Appl Phys Lett 2000, 77:2698–2700.CrossRef 22. Tung RT: Electron transport at metal–semiconductor interfaces: general theory. Phys Rev B 1992, 45:13509–13523.CrossRef 23. Zhang ML, Peng KQ, Fan X, Jie JS, Zhang RQ, Lee ST, Wong NB: Preparation of large-area uniform silicon nanowires Cilengitide clinical trial arrays through metal-assisted chemical etching. J Phys Chem C 2008, 112:4444–4450.CrossRef Vactosertib 24. Cruz S, Hönig-d’Orville A, Müller J: Fabrication and optimization of porous silicon substrates for diffusion membrane applications. J Electrochem Soc 2005, 152:C418-C424.CrossRef 25. Li X, Bohn PW: Metal-assisted chemical etching in HF/H 2 O 2 produces porous silicon. Appl Phys Lett 2000, 77:2572–2574.CrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions ZZ carried out
the preparation and main characterization of the SiNWs and drafted the manuscript. GC participated in its design and coordination. YS participated in the design of the study. YL participated in the data analysis and English description modification. GJ participated of in the mechanism analysis of
different etching rates of SiNWs. All authors read and approved the final manuscript.”
“Background Angiogenesis is the most common process of new blood vessel development. Growth of new vessels starts from pre-existing ones and consists of two main processes: sprouting (RAD001 solubility dmso endothelial cell migration) and intussusception (splitting of vessels) [1, 2]. The growth of blood vessels depends on a balance between angiogenesis-promoting and angiogenesis-inhibiting signalling molecules. Vascular network growth is an essential process, especially during embryonic development, tissue remodelling and regeneration. However, disorders in blood vessel development may foster diseases like chronic inflammatory disorders. Development of new vessels is also essential for the growth and metastasis of tumours, in which pro-angiogenic molecules like vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) play critical roles. Binding of FGF and especially VEGF, which is considered a major molecule controlling blood vessel morphogenesis, to their tyrosine kinase receptors activates multiple downstream molecules involved in different signalling pathways that lead to increased vascular permeability, cell migration and proliferation [3].